Study of Therapeutic Targets Tailored Ch and IMRT as Neoadjuvant Treatment in Rectal Carcinoma Patients

NCT01366118 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Rectal Cancer

Interventions

DRUG: Therapeutic target tailored chemotherapy

Sponsor

Grupo Hospital de Madrid